Intellectual Property India Publishes Patent Application for 'Pharmaceutical Compositions Comprising Anti-Human Tslp Receptor Antibodies And Methods Of Using The Same' Filed by Upstream Bio, Inc.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517051333 A) filed by Upstream Bio, Inc., Waltham, U.S.A., on May 28, for 'pharmaceutical compositions comprising anti-human tslp receptor antibodies and methods of using the same.'

Inventor(s) include Petaipimol, Parika; Gearing, Patrick R.; Wang, Bingquan; Li, Geng; and Guo, Jeremy.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "Pharmaceutical compositions of anti-TSLP-R antibodies, and uses thereof, are provided herein. The pharmaceutical compositions can comprise for example, an anti-TSLP- R antibody, or antigen-binding fragment thereof, a pharmaceutically acceptable buffer, an excipient, and a surfactant, or other compositions as provided for herein."

The patent application was internationally filed on Nov. 07, 2023, under International application No.PCT/US2023/078873.

Disclaimer: Curated by HT Syndication.